Human cytomegalovirus inhibits erythropoietin production

Journal of the American Society of Nephrology

Volumn 25, Issue 8, 2014, Pages 1669-1678

  Butler, Lynn M ^a   Dzabic, Mensur ^a   Bakker, Frank ^a   Davoudi, Belghis ^a   Jeffery, Hannah ^a   Religa, Piotr ^a   Bojakowski, Krzysztof ^b   Yaiw, Koon Chu ^a   Rahbar, Afsar ^a   Söderberg Naucler, Cecilia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN G; MESSENGER RNA; VALGANCICLOVIR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ERYTHROCYTE COUNT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; LYMPHOCYTE COUNT; MEAN CORPUSCULAR HEMOGLOBIN; MOUSE; MURINE CYTOMEGALOVIRUS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE CELL ANALYSIS; ANIMAL; BLOOD; CELL HYPOXIA; CHRONIC KIDNEY FAILURE; CULTURE TECHNIQUE; CYTOMEGALOVIRUS; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CYTOMEGALOVIRUS; ERYTHROCYTE COUNT; ERYTHROPOIETIN; HEMOGLOBINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOGLOBULIN G; MICE; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER;

EID: 84921652121     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013101125     Document Type: Article

References (33)

1. Lorenz M, Kletzmayr J, Perschl A, Furrer A, HörlWH, Sunder-Plassmann G: Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13: 794-797, 2002
2. Shah N, Al-Khoury S, Afzali B, Covic A, Roche A, Marsh J, Macdougall IC, Goldsmith DJ: Posttransplantation anemia in adult renal allograft recipients: Prevalence and predictors. Transplantation 81: 1112-1118, 2006
3. Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G: A prospective study of anaemia and long-term outcomes in kidney transplant recipients.NephrolDial Transplant21: 3559-3566,2006
4. VanrenterghemY, Ponticelli C,Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F: Prevalence andmanagement of anemia in renal transplant recipients: A European survey. Am J Transplant 3: 835-845, 2003
5. Vanrenterghem Y: Anaemia after renal transplantation. Nephrol Dial Transplant 19[Suppl 5]: V54-V58, 2004
6. Lankhorst CE, Wish JB: Anemia in renal disease: diagnosis and management. Blood Rev 24: 39-47, 2010
7. JelkmannW: Molecular biology of erythropoietin. InternMed 43: 649-659, 2004
8. Fishbane S: Review: Recombinant human erythropoietin decreases the need for blood transfusions and may delay dialysis in chronic renal failure. ACP J Club 136: 85, 2002
9. Bachmann S, Le Hir M, Eckardt KU: Co-localization of erythropoietin mRNA and ecto-59-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41: 335-341, 1993
10. Webb JD, Coleman ML, Pugh CW: Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. CellMol Life Sci 66: 3539-3554, 2009
11. Furlow PW, Percy MJ, Sutherland S, Bierl C, McMullin MF, Master SR, Lappin TR, Lee FS: Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline. J Biol Chem284: 9050-9058, 2009
12. Kapitsinou PP, Liu Q, Unger TL, Rha J, Davidoff O, Keith B, Epstein JA, Moores SL, Erickson-Miller CL, Haase VH: Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. Blood 116: 3039-3048, 2010
13. De Keyzer K, Van Laecke S, Peeters P, Vanholder R: Human cytomegalovirus and kidney transplantation: A clinician's update. Am J Kidney Dis 58: 118-126, 2011
14. Ustinov JA, Loginov RJ, Mattila PM, Nieminen VK, Suni JI, Häyry PJ, Lautenschlager IT: Cytomegalovirus infection of human kidney cells in vitro. Kidney Int 40: 954-960, 1991
15. DzabicM, Rahbar A, Yaiw KC, NaghibiM, Religa P, FellströmB, Larsson E, Söderberg-Nauclér C: Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. Clin Infect Dis 53: 969-976, 2011
16. Gerstenkorn C, Robertson H, MohamedMA,O'DonnellM, Ali S, Talbot D: Detection of cytomegalovirus (CMV) antigens in kidney biopsies and transplant nephrectomies as a marker for renal graft dysfunction. Clin Chem Lab Med 38: 1201-1203, 2000
17. Li YT, Emery VC, Surah S, Jarmulowicz M, Sweny P, Kidd IM, Griffiths PD, Clark DA: Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long-term graft function.JMed Virol 82: 85-93, 2010
18. Helanterä I, Koskinen P, Finne P, Loginov R, Kyllönen L, Salmela K, Grönhagen-Riska C, Lautenschlager I: Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int 19: 893-900, 2006
19. Einollahi B, Lessan-Pezeshki M, Rostami Z, Kalantar E, Afshar R, Beiraghdar F: Anemia after kidney transplantation in adult recipients: Prevalence and risk factors. Transplant Proc 43: 578-580, 2011
20. Pliquett RU, Klein C, Grünewald T, Ruf BR, Beige J: Lack of evidence for systemic cytomegalovirus reactivation in maintenance hemodialysis patients. Eur J Clin Microbiol Infect Dis 30: 1557-1560, 2011
21. Yadav AK, Jha V: CD4+CD28null cells are expanded and exhibit a cytolytic profile in end-stage renal disease patients on peritoneal dialysis. Nephrol Dial Transplant 26: 1689-1694, 2011
22. Betjes MG, Weimar W, Litjens NH: CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD. J Am Soc Nephrol 20: 2661-2666, 2009
23. Lagneaux L, Delforge A, Snoeck R, Bosmans E, Moreau JF, Taupin JL, De Clercq E, Stryckmans P, Bron D: Human cytomegalovirus increases constitutive production of interleukin-6 and leukemia inhibitory factor by bone marrow stromal cells. Blood 87: 59-66, 1996
24. Geist LJ, Dai LY: Cytomegalovirus modulates interleukin-6 gene expression. Transplantation 62: 653-658, 1996
25. Betjes MG, Litjens NH, Zietse R: Seropositivity for cytomegalovirus in patients with end-stage renal disease is strongly associated with atherosclerotic disease. Nephrol Dial Transplant 22: 3298-3303, 2007
26. Wang EC: CD4+ T cells, human cytomegalovirus and end-stage renal disease. Nephrol Dial Transplant 26: 1467-1470, 2011
27. Betjes MG, Huisman M, Weimar W, Litjens NH: Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int 74: 760-767, 2008
28. Derry MC, Sutherland MR, Restall CM, Waisman DM, Pryzdial EL: Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5. J Gen Virol 88: 19-27, 2007
29. Wang Z, Goldberg MA, Scadden DT: HIV-1 suppresses erythropoietin production in vitro. Exp Hematol 21: 683-688, 1993
30. Wang GL, Jiang BH, Rue EA, Semenza GL: Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92: 5510-5514, 1995
31. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12: 5447-5454, 1992
32. Percy MJ, Mooney SM, McMullin MF, Flores A, Lappin TR, Lee FS: A common polymorphism in the oxygen-dependent degradation (ODD) domain of hypoxia inducible factor-1alpha (HIF-1alpha) does not impair Pro-564 hydroxylation. Mol Cancer 2: 31, 2003
33. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC: Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104: 2301-2306, 2007